<DOC>
	<DOCNO>NCT02580838</DOCNO>
	<brief_summary>The aim study determine whether early use OnabotulinumtoxinA effective improve functional outcome upper limb patient stroke .</brief_summary>
	<brief_title>The Effects Early Late Injection Botulinum Toxin Type A Upper Limb Function Patients With Stroke</brief_title>
	<detailed_description>Many patient survive stroke significant impairment function affect upper limb due development spasticity . Botulinum toxin type A injection powerful treatment option control spasticity . In study , patient randomly assign three group : early OnabotulinumtoxinA group receive OnabotulinumtoxinA injection spasticity develop , late OnabotulinumtoxinA group injection 6 month emergence spasticity , third group OnabotulinumtoxinA intervention . The aim randomize control study evaluate effect early late injection botulinum toxin type A upper limb function patient stroke .</detailed_description>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>onabotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins , Type A</mesh_term>
	<mesh_term>abobotulinumtoxinA</mesh_term>
	<mesh_term>incobotulinumtoxinA</mesh_term>
	<mesh_term>Botulinum Toxins</mesh_term>
	<criteria>stroke affect one body side spasticity develop stroke musculoskeletal condition affect upper limb function prior stroke concurrent use antispasticity medication patient neuromuscular junction myopathic disorder myasthenia gravis others patient know allergy onabotulinumtoxinA excipients onabotulinumtoxinA ( human serum albumin ) patient pregnant may become pregnant time propose injection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Stroke</keyword>
	<keyword>Spasticity</keyword>
	<keyword>OnabotulinumtoxinA</keyword>
</DOC>